+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

, : Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Research & Therapy 14(3): R141-R141

Prevalence of insulin resistance and the metabolic syndrome has been reported to be high in rheumatoid arthritis (RA) patients. Tumor necrosis factor (TNF), a pro-inflammatory cytokine with a major pathogenetic role in RA, may promote insulin resistance by inducing Ser312 phosphorylation (p-Ser312) of insulin receptor substrate (IRS)-1 and downregulating phosphorylated (p-)AKT. We examined whether anti-TNF therapy improves insulin resistance in RA patients and assessed changes in the insulin signaling cascade. Prospective study of RA patients receiving anti-TNF agents (infliximab, n = 49, adalimumab, n = 11, or etanercept, n = 1) due to high disease activity score in 28 joints (DAS28 >5.1). A complete biochemical profile was obtained at weeks and 12 of treatment. Insulin resistance, insulin sensitivity and pancreatic beta cell function were measured by the Homeostasis Model Assessment (HOMA-IR), the Quantitative Insulin Sensitivity Check Index (QUICKI) and the HOMA-B respectively. Protein extracts from peripheral blood mononuclear cells were assayed by western blot for p-Ser312 IRS-1 and p-AKT. RA patients treated with abatacept (CTLA4.Ig) were used as a control group for insulin signaling studies. At study entry, RA patients with high insulin resistance (HOMA-IR above median) had significantly higher mean DAS28 (P = .11), serum triglycerides (P = .15), and systolic blood pressure levels (P = .24) than patients with low insulin resistance. After 12 weeks of anti-TNF therapy, patients with high insulin resistance demonstrated significant reduction in HOMA-IR (P<.1), HOMA-B (P = .1), serum triglycerides (P = .39), and increase in QUICKI (P<.1) and serum HDL-C (P = .22). Western blot analysis in seven active RA patients with high insulin resistance showed reduction in p-Ser312 IRS-1 (P = .43) and increase in p-AKT (P = .1) over the study period. In contrast, the effect of CTLA4.Ig on p-Ser312 IRS-1 and p-AKT levels was variable. Anti-TNF therapy improved insulin sensitivity and reversed defects in the insulin signaling cascade in RA patients with active disease and high insulin resistance. The impact of these biochemical changes in modifying cardiovascular disease burden in active RA patients remains to be seen.


PMID: 22691241

DOI: 10.1186/ar3874

Other references

Napier, B.W.; Senatore, R.U., 1988: They do clean burs ... don't they?. Journal of the Dental Association of South Africa 43(12): 585-585

Kelly, J.G., 2002: The spirit of community psychology. 2001 Seymour B. Sarason Award Address. Community psychology as a field may have lost some of its original spirit; a spirit dominant at the founding of the field. Spirit is a difficult concept to discuss since it is a concept beyond usual discourse in psychology as a denotative, measura...

Kustareva, K.S.; Nadezhdina, E.A.; Kuliabko, O.M., 1970: Application of ultraviolet erithemotherapy to stimulate resistance of the organism in children with protracted course of rheumatism. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury 35(2): 125-130

Tooyama, I.; Kawamata, T.; Akiyama, H.; Moestrup, S.K.; Gliemann, J.; McGeer, P.L., 1993: Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain. Localization of the alpha 2 macroglobulin receptor (alpha 2MR) was studied in postmortem human brain tissue of Alzheimer disease (AD) and age-matched control cases with a monoclonal antibody (A2MR alpha 2) to the receptor. In control cases alpha 2...

Perrin L.H.; Zubler R.; Hirschel B.; Martin J.L.; Salomon D.; Saurat J.H.; Fryc O., 1988: Reversal of positive serology for human immunodeficiency virus. The medical history and laboratory data of two persons who have been in contract with HIV1 positive carrier individuals are reported. The serologic data of successive serum samples collected from these persons were first negative, then positive (i...

Sanger, D.J., 1976: Scopolamine and adjunctive drinking in rats. Nine, food-deprived rats were each given daily sessions during which 60 45-mg food pellets were delivered individually at 60-s intervals, independently of behavior. Water spouts were available to the animals, and the intermittent delivery of food...

Laessoe, T.; Spooner, B.M., 1993: Physalacria cryptomeriae Berthier and Rogerson in Mycologia 63 643. Mycologist 7(4): 162

Kamihira, S.; Kinoshita, K.; Ikeda, S.; Yamada, Y., 1979: Clinical and geographic characteristics of T-cell malignancies in Nagasaki District. Japanese Journal of Clinical Hematology 20(9): 1048-1055

Jessurun, J.; Romo-Garcia, J.; Lopez-Denis, O.; Olvera-Rabiela, J.E., 1990: Crusted scabies in a patient with the acquired immunodeficiency syndrome. A case of crusted (Norwegian) scabies in a patient with the acquired immunodeficiency syndrome (AIDS) is described and seven previous reports of this association are reviewed. Injury to epidermal Langerhans' cells by the human immunodeficienc...

Park, C.; Zhang, H.; Peng, M.; Bissell, M., 2003: Cell-microenvironment mediated radiation response in breast cancer. Breast Cancer Research & Treatment 82(Supplement 1): S183